Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice
Advanced Biology · 2023
DOI: 10.1002/adbi.202300154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2023. Verfasst von Eliezer Z Lichter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Hauptthemen laut MEDLINE: Brain, Heart, Genome, Mitochondrial, DNA Polymerase gamma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Mitochondrial dysfunction has been implicated in neurodegenerative diseases like Parkinson's disease (PD). This study investigates the role of Parkin, a protein involved in mitochondrial quality control, and strongly linked to PD, in the context of mitochondrial DNA (mtDNA) mutations. Mitochondrial mutator mice (Polg D257A/D257A ) (Polg) are used and bred with Parkin knockout (PKO) mice or mice with disinhibited Parkin (W402A). In the brain, mtDNA mutations are analyzed in synaptosomes, presynaptic neuronal terminals, which are far from neuronal soma, which likely renders mitochondria there more vulnerable compared with brain homogenate. Surprisingly, PKO results in reduced mtDNA mutations in the brain but increased control region multimer (CRM) in synaptosomes. In the heart, both PKO and W402A lead to increased mutations, with W402A showing more mutations in the heart than PKO. Computational analysis reveals many of these mutations are deleterious. These findings suggest that Parkin plays a tissue‐dependent role in regulating mtDNA damage response, with differential effects in the brain and heart. Understanding the specific role of Parkin in different tissues may provide insights into the underlying mechanisms of PD and potential therapeutic strategies. Further investigation into these pathways can enhance the understanding of neurodegenerative diseases associated with mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- School of Interdisciplinary Informatics, University of Nebraska Omaha, Omaha, NE, 68182, USA.
ORCID-Profile: Howard S Fox
Förderung
- Michael J. Fox Foundation for Parkinson's Research
Zitieren
APA
Lichter, E. Z., Trease, A. J., Cooper, K., Stauch, K. L., & Fox, H. S. (2023). Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice. Advanced Biology. https://doi.org/10.1002/adbi.202300154
Vancouver
Lichter EZ, Trease AJ, Cooper K, Stauch KL, Fox HS. Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice. Advanced Biology. 2023. doi:10.1002/adbi.202300154
BibTeX
@article{Lichter2023,
author = {Lichter, Eliezer Z and Trease, Andrew J and Cooper, Kathryn and Stauch, Kelly L and Fox, Howard S},
title = {Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice},
journal = {Advanced Biology},
year = {2023},
doi = {10.1002/adbi.202300154}
}
EUVIMED